Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
STLK 0.0002 -33.33 180533047
RMRK 0.0002 -50 68091535
GDSM 0.0002 0 59496919
NSAV 0.0002 0 42989997
FOGC 0.0002 0 28214668
GBGM 0.0002 100 26697048
UMNG 0.0002 0 25549076
NSEH 0.0002 100 16612500
IFLM 0.0002 0 16427777
SVFC 0.0002 0 13154010
SFOR 0.0002 0 12779371
TADF 0.0002 0 12042000
YTRV 0.0002 0 11849998
MDCE 0.0002 0 11642000
AGCZ 0.0002 0 10159102
BOPT 0.0002 0 9368821
SNDY 0.0002 0 9113703
NBRI 0.0002 0 8265505
CFGX 0.0002 0 7977500
CFGX 0.0002 0 7977500
TALK 0.0002 0 6880000
RIGH 0.0002 0 5893499
SKTO 0.0002 0 5678563
FCGD 0.0002 0 4221725
SMAA 0.0002 0 3336293
SMAA 0.0002 0 3336293
PIHN 0.0002 0 2742000
WTWO 0.0002 0 2160000
RFMK 0.0002 0 2143500
ATTD 0.0002 0 2049999

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last